Alimera Sciences
ALIM
ALIM was delisted on the 13th of September, 2024.
60 hedge funds and large institutions have $129M invested in Alimera Sciences in 2014 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 15 reducing their positions, and 4 closing their positions.
236% more call options, than puts
Call options by funds: $6.25M | Put options by funds: $1.86M
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
73% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 15
7% more funds holding
Funds holding: 56 → 60 (+4)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
30% less capital invested
Capital invested by funds: $185M → $129M (-$55.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NRC
North Run Capital
Boston,
Massachusetts
|
+$1.98M |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$982K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$892K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$841K |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$653K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$10.9M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$2.85M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$2.37M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$866K |
| 5 |
Jane Street
New York
|
-$777K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Ameriprise
Minneapolis,
Minnesota
| $32K | +$23.8K | +268 | +295% |
|
52
Citigroup
New York
| $20K | -$144K | -1,617 | -88% |
|
53
AllianceBernstein
Nashville,
Tennessee
| $19K | +$18.9K | +213 | New |
|
|
VFA
54
Virtus Fund Advisers
Hartford,
Connecticut
| $13K | +$13.2K | +149 | New |
|
55
Wells Fargo
San Francisco,
California
| $11K | +$10.9K | +123 | +12,300% |
|
|
U
56
UBS
Zurich,
Switzerland
| $7K | +$6.66K | +75 | New |
|
57
Bank of Montreal
Toronto,
Ontario, Canada
| $3K | +$3.29K | +37 | New |
|
58
BNP Paribas Financial Markets
Paris,
France
| $2.51K | -$1.86K | -21 | -43% |
|
59
Barclays
London,
United Kingdom
| $2K | -$1.51K | -17 | -34% |
|
60
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $1K | – | – | – |
|
|
61
Invesco
Atlanta,
Georgia
| – | -$2.85M | -24,071 | Closed |
|
|
ZIM
62
Zacks Investment Management
Chicago,
Illinois
| – | -$270K | -2,282 | Closed |
|
|
GC
63
Guggenheim Capital
Chicago,
Illinois
| – | -$88K | -747 | Closed |
|
64
Creative Planning
Overland Park,
Kansas
| – | -$1K | -7 | Closed |
|
ALIM Hedge Fund Activity: Q2 2014 in Review
60 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q2 2014, worth a combined $129M — down 30% from $185M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ALIM positions and 4 closed out — a net gain of 4 holders — while 26 added to existing stakes and 15 trimmed.
The largest buyer was North Run Capital, adding an estimated $1.98M. The largest seller was Columbia Wanger Asset Management, cutting an estimated $10.9M.
- 60 institutional investors held Alimera Sciences (ALIM) as of Q2 2014, up from 56 in Q1 2014.
- Funds reported $129M of Alimera Sciences stock for Q2 2014, down 30% quarter-over-quarter.
- 8 funds opened new Alimera Sciences positions in Q2 2014 and 4 closed out, a net change of +4 holders.
- The largest Alimera Sciences buyer in Q2 2014 was North Run Capital, an estimated $1.98M added.
- The largest Alimera Sciences seller in Q2 2014 was Columbia Wanger Asset Management, an estimated $10.9M sold.
Based on aggregated 13F filings for Q2 2014.